Insmed Incorporated
$139.60
$0.41(-0.29%)
Insmed Incorporated
INSM
$139.60
$0.41(-0.29%)
Insmed Incorporated
INSM
NASDAQ
$139.60
$0.41(-0.29%)
Chart
Upcoming Earnings
Next report date
May 7, 2026
Report period
Q2 2026
EPS Estimate
$-0.97
Revenue Estimate
$299.05M
Key stats
52-Week Range$139.60
$63.81
$212.75
Market capitalization
$30.10BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-22.30Basic EPS (TTM)
$-6.41Net income (TTM)
$-1.28BRevenue (TTM)
$606.42MAvg. volume
2.25MBeta (1Y)
0.89Employees
1.27KMarket capitalization
$30.10BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-22.30Basic EPS (TTM)
$-6.41Net income (TTM)
$-1.28BRevenue (TTM)
$606.42MAvg. volume
2.25MBeta (1Y)
0.89Employees
1.27KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Insmed Incorporated
Sector
Healthcare
Industry
Biotechnology
CEO
William H. Lewis
Website
www.insmed.comHeadquarters
700 US Highway 202/206, Bridgewater, NJ, 08807
IPO Date
2000-06-01
Identifiers
ISIN
US4576693075Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases....
Related Stocks
$16.55
1D:
-0.1%
1Y:
7.6%
US8740602052Healthcare
Mkt Cap
$52.28B
P/E Ratio TTM
73.3
Revenue TTM
$4.49T
Beta
0.13
Earnings TTM
$114.75B
Dividend Yield TTM
3.82%
$197.00
1D:
-0.0%
1Y:
29.6%
US14149Y1082Healthcare
Mkt Cap
$46.36B
P/E Ratio TTM
29.4
Revenue TTM
$244.49B
Beta
0.65
Earnings TTM
$1.67B
Dividend Yield TTM
1.05%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate